霍亂疫苗市場規模、佔有率和成長分析（按類型、產品類型、給藥途徑、最終用戶、年齡層、通路和地區分類）－2026-2033年產業預測

預計到 2024 年，全球霍亂疫苗市場規模將達到 8,670 萬美元，到 2025 年將成長至 9,372 萬美元，到 2033 年將成長至 1.7476 億美元，預測期（2026-2033 年）的複合年成長率為 8.1%。

霍亂主要透過受污染的食物和水傳播，仍然是全球面臨的重大公共衛生挑戰。此疾病的症狀包括嚴重腹瀉、脫水和腹痛，以及心搏過速和低血壓等全身性併發症。接種疫苗是重要的預防措施，可透過靜脈注射、肌肉注射和口服等多種途徑增強人體對霍亂弧菌的免疫力。作為一種有效的生物製藥，霍亂疫苗在對抗這種與衛生條件差和缺乏安全飲用水密切相關的感染疾病中至關重要。包括世界衛生組織（世衛組織）在內的國際衛生組織持續推廣疫苗接種，將其作為控制霍亂疫情和增強受影響地區公共衛生韌性的關鍵策略。

全球霍亂疫苗市場成長要素

全球霍亂疫苗市場預計將因多種因素而成長，包括疫苗研發領域的創新方法以及公眾對霍亂預防重要性的認知不斷提高。不良的生活習慣，例如衛生條件不佳和食用受污染的食物，也加劇了霍亂疫情的持續蔓延，從而推動了疫苗需求。此外，各國政府衛生機構對疫苗接種計畫的日益重視預計也將進一步促進市場擴張。然而，監管機構對新疫苗引進的嚴格要求以及漫長的核准流程可能會給市場帶來挑戰。

限制全球霍亂疫苗市場的因素

疫苗研發週期長、監管核准要求嚴格，可能對全球霍亂疫苗市場的擴張構成重大挑戰。這些因素可能延緩新產品上市，最終阻礙對霍亂疫情的快速反應能力。此外，複雜的監管環境也可能抑制創新，阻礙投資。這可能會限制市場的整體成長潛力，並限制霍亂疫區民眾獲得必要疫苗的機會，進而對全球公共衛生造成潛在影響。

全球霍亂疫苗市場趨勢

全球霍亂疫苗市場正經歷顯著成長，主要受霍亂發病率上升的推動，而霍亂發病率上升與衛生條件差密切相關，尤其是在農村和偏遠地區。民眾對接種疫苗作為預防霍亂疫情措施重要性的認知不斷提高，進一步推動了這一趨勢。各國政府和衛生組織正將舉措列為優先事項，以減輕霍亂的影響，進而推動市場需求。此外，疫苗研發和分發策略的持續創新有望提高疫苗的可及性和覆蓋率，進一步鞏固全球霍亂疫苗的市場環境。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球霍亂疫苗市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 全細胞霍亂弧菌O1（含重組B次單元）
• 去活化的口服 O1 和 O139

全球霍亂疫苗市場規模（按產品和複合年成長率分類）（2026-2033 年）

• Vaxchora
• 杜可樂
• 尚科爾
• 其他產品

全球霍亂疫苗市場規模（依給藥途徑及複合年成長率分類）（2026-2033 年）

• 注射疫苗
• 口服疫苗

全球霍亂疫苗市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 居家醫療
• 專科診所
• 其他

全球霍亂疫苗市場規模（依年齡層分類）及複合年成長率（2026-2033 年）

• 成人
• 兒童

全球霍亂疫苗市場規模（依分銷管道分類）及複合年成長率（2026-2033 年）

• 醫院藥房
• 網路藥房
• 零售藥房

全球霍亂疫苗市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Valneva SE（France）
• Sanofi（France）
• Emergent BioSolutions（USA）
• EuBiologics（South Korea）
• Shantha Biotechnics（India）
• Hilleman Laboratories（Singapore）
• Astellas Pharma（Japan）
• Incepta Vaccine（Bangladesh）
• Vabiotech（France）
• Bharat Biotech（India）
• Biological E.（India）
• Serum Institute of India（India）
• Panum Institute（Denmark）
• Walter Reed Army Institute of Research（USA）
• National Institutes of Health（NIH）（USA）
• World Health Organization（WHO）（Switzerland）
• Centers for Disease Control and Prevention（CDC）（USA）
• Medecins Sans Frontieres（MSF）（Switzerland）
• PATH（USA）

結論與建議

Global Cholera Vaccines Market size was valued at USD 86.7 Million in 2024 and is poised to grow from USD 93.72 Million in 2025 to USD 174.76 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

Cholera remains a significant global public health challenge, primarily transmitted through contaminated food and water. The disease manifests through symptoms such as severe diarrhea, dehydration, abdominal pain, and systemic complications like rapid heartbeat and low blood pressure. Vaccination serves as an essential preventive measure, facilitating the body's immunity against the cholera bacteria through various administration methods, including intravenous, intramuscular, and oral. As a viable biological preparation, the cholera vaccine is pivotal in combating this infectious disease, which is closely linked to poor sanitation and access to safe drinking water. Global health organizations, including the World Health Organization, continue to advocate for vaccination as a crucial strategy to mitigate cholera outbreaks and enhance public health resilience in affected regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholera Vaccines Market Segments Analysis

Global Cholera Vaccines Market is segmented by Type, Product, Route of Administration, End User, Age Group, Distribution Channel and region. Based on Type, the market is segmented into Whole Cell V. Cholerae O1 with Recombinant B- subunit and Killed Oral O1 and O139. Based on Product, the market is segmented into Vaxchora, Dukoral, Shanchol and Other Products. Based on Route of Administration, the market is segmented into Injectables Vaccines and Oral Vaccines. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on Age Group, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholera Vaccines Market

The global cholera vaccines market is poised for growth due to a combination of factors, including innovative approaches to vaccine development and heightened public awareness regarding the importance of cholera prevention. Unhealthy lifestyle choices, such as inadequate sanitation and the consumption of contaminated food, further contribute to the ongoing challenge of cholera outbreaks, thereby driving demand for vaccines. Additionally, increased emphasis on immunization initiatives by governmental health organizations is expected to further enhance market expansion. However, the market could face challenges from stringent regulatory requirements and extended approval processes imposed by authorities overseeing new vaccine introductions.

Restraints in the Global Cholera Vaccines Market

The extended time required for vaccine development, combined with the necessity for rigorous regulatory approvals, may pose significant challenges to the expansion of the global cholera vaccines market. These factors can create delays in bringing new products to market, ultimately hampering the ability to respond swiftly to cholera outbreaks. Additionally, navigating the complex landscape of regulatory compliance can impede innovation and discourage investment. As a result, the overall growth potential for the market may be restrained, limiting access to much-needed vaccination options for regions highly affected by cholera and affecting public health outcomes globally.

Market Trends of the Global Cholera Vaccines Market

The global cholera vaccines market is experiencing significant growth, propelled by the rising incidence of cholera linked to inadequate sanitation and hygiene conditions, particularly in rural and isolated regions. This trend is further fueled by heightened public awareness surrounding the importance of vaccination as a preventive measure against cholera outbreaks. Governments and health organizations are increasingly prioritizing vaccination initiatives to mitigate the disease's impact, thus enhancing market demand. Additionally, ongoing innovations in vaccine development and distribution strategies are expected to expand access and outreach, fostering a more robust market environment for cholera vaccines globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cholera Vaccines Market Size by Type & CAGR (2026-2033)

• Market Overview
• Whole Cell V. Cholerae O1 with Recombinant B- subunit
• Killed Oral O1 and O139

Global Cholera Vaccines Market Size by Product & CAGR (2026-2033)

• Market Overview
• Vaxchora
• Dukoral
• Shanchol
• Other Products

Global Cholera Vaccines Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Injectables Vaccines
• Oral Vaccines

Global Cholera Vaccines Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Cholera Vaccines Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Adults
• Children

Global Cholera Vaccines Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Cholera Vaccines Market Size & CAGR (2026-2033)

• North America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Valneva SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuBiologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shantha Biotechnics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hilleman Laboratories (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incepta Vaccine (Bangladesh)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vabiotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panum Institute (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walter Reed Army Institute of Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• National Institutes of Health (NIH) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Health Organization (WHO) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centers for Disease Control and Prevention (CDC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medecins Sans Frontieres (MSF) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PATH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations